Replacement | Medicines | 10/02/2011

The marketing authorization holder has informed its supplied customers that results from stability data indicate a possible shortfall of the required active ingredient content by the end of the shelf life. The affected batch currently meets all quality and efficacy requirements, and the recall is being implemented solely as a precautionary measure and will be replaced with new, unaffected product.

Name of the medicinal product Vivotif - Kapseln
Marketing authorisation number(s) 2-00011
Marketing authorisation holder Crucell Italy Srl

Vertrieb: Baxter Healthcare GmbH
Batch number(s) 3001835
Expiry date 09/04/2019
Classification of the recall3
BASG reference number INS-640.001-0003

Further inquiry note